Abstract:BACKGROUND: The alternative transcriptional isoform of Bruton's tyrosine kinase, BTK-C, is expressed in a wide variety of epithelial tumor types where it impacts apoptosis resistance, therapeutic escape, and glucose uptake. The initial exon in BTK-C encodes a 34 amino acid extension of the amino terminus of the canonical BTK-A isoform. Its function is unknown.MATERIALS AND METHODS: Site-directed mutagenesis, acylation assays and expression studies in cancer cell lines were used to determine the effects that the BTK-C first exon sequence has on kinase activity, subcellular localization and cell physiology. Analysis of BTK-C expression in tumors was conducted using genomic databases.RESULTS: BTK-C is palmitoylated on two cysteine residues. BTK-C localization at the plasma membrane is dependent upon phosphatidylinositol 3,4,5-triphosphate (PIP<sub>3</sub>) levels as well as palmitoylation. In epithelial cancer cells, both BTK-A and BTK-C isoforms are recruited to the plasma membrane; however, BTK-A also localizes to the nucleus whereas BTK-C has a primarily perinuclear distribution. Transcription of the BTK-C isoform is inversely correlated with expression of commonly activated breast cancer signaling receptors in breast tumors. In MDA-MB-231 cells, BTK-C expression confers modest increases in proliferation and glucose uptake rates compared to BTK-A.CONCLUSION: Palmitoylation affects localization and regulation of BTK-C in epithelial tumor cells where it functions as an important survival factor. Expression of either palmitoylated or non-palmitoylated kinase isoforms that function in PI3K signaling may be a common regulatory feature as nine other soluble kinases in the human genome possess similarly encoded alternative N-termini (ANT).

Functional Role of the Flexible N-terminal Extension of FKBP38 in Catalysis.

Conformation and Dynamics of the C-terminal Region in Human Phosphoglycerate Mutase 1

Palmitoylation of the Alternative Amino Terminus of the BTK-C Isoform Controls Subcellular Distribution and Signaling

Structure of the N-terminal domain of human FKBP52.

Binding Modes and Conformational Changes of FK506-binding Protein 51 Induced by Inhibitor Bindings: Insight into Molecular Mechanisms Based on Multiple Simulation Technologies

Three-dimensional Structure of Human FKBP52

Kinase Activity of Casein Kinase 1 Delta (ck1δ) is Modulated by Protein Kinase C Α (pkcα) by Site-Specific Phosphorylation Within the Kinase Domain of CK1δ

Roles of Amino Acid Residues H66 and D326 in the Creatine Kinase Activity and Structural Stability

FKBP12-BOUND CALCINEURIN CONTROL TMEM16A ACTIVITY

Structural Characterization of the RyR1-FKBP12 Interaction.

A distinct interaction mode revealed by the crystal structure of the kinase p38α with the MAPK binding domain of the phosphatase MKP5.

Regulation of Protein Kinase C Inactivation by Fas-associated Protein with Death Domain

PYK2 senses calcium through a disordered dimerization and calmodulin-binding element

Catalysis-Based Inhibitors Of The Calcium Signaling Function Of Cd38

Localization of the FK506-binding protein, FKBP 13, to the lumen of the endoplasmic reticulum

Catalysis-associated Conformational Changes Revealed by Human CD38 Complexed with a Non-Hydrolyzable Substrate Analog.

Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK-506 binding protein: evidence for the existence of a family of distinct enzymes

Localization of the 12.6-kDa FK506-binding Protein (FKBP12.6) Binding Site to the NH2-terminal Domain of the Cardiac Ca2+ Release Channel (Ryanodine Receptor)

Architecture of the MKK6-p38α complex defines the basis of MAPK specificity and activation

Structural Insights into the Mechanism of Calmodulin Binding to Death Receptors

Prevention of calpain-dependent degradation of STK38 by MEKK2-mediated phosphorylation